Ultravist 370 and Cardiac arrest - a phase IV clinical study of FDA data

Summary:

Cardiac arrest is reported as a side effect among people who take Ultravist 370 (iopromide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Sorafenib, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Cardiac arrest when taking Ultravist 370. It is created by eHealthMe based on reports of 1,333 people who have side effects when taking Ultravist 370 from the FDA, and is updated regularly.

What is Ultravist 370?

Ultravist 370 has active ingredients of iopromide. eHealthMe is studying from 1,334 Ultravist 370 users. Check the latest studies of Ultravist 370.

What is Cardiac arrest?

Cardiac arrest is found to be associated with 2,236 drugs and 2,512 conditions by eHealthMe. Check the latest studies of Cardiac arrest.

On Jul, 07, 2026

1,333 people reported to have side effects when taking Ultravist 370.
Among them, 68 people (5.1%) have Cardiac arrest.

Could Ultravist 370 cause Cardiac arrest?

Among these 68 people:

How long have people been on Ultravist 370 when they have Cardiac arrest? *

What is the gender of people who have Cardiac arrest when taking Ultravist 370? *

female: 47.69 %
male: 52.31 %

What is the age of people who have Cardiac arrest when taking Ultravist 370? *

What are other drugs people take besides Ultravist 370? *

What are other side effects people have besides Cardiac arrest? *

Breathing - Slowed Or Stopped: 10 people, 14.71%
Hypotension (abnormally low blood pressure): 9 people, 13.24%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 6 people, 8.82%
Heart Disease: 6 people, 8.82%
Loss Of Consciousness: 5 people, 7.35%
Dyspnea (difficult or laboured breathing): 5 people, 7.35%
Nausea And Vomiting: 5 people, 7.35%
Nausea (feeling of having an urge to vomit): 4 people, 5.88%
Lividity (a tissue condition of being red or blue because of venous congestion, as in a contusion): 3 people, 4.41%
Skin Discoloration - Bluish (bluish colour of skin): 3 people, 4.41%

What are the existing conditions these people have? *

Computerised Tomogram Abdomen: 10 people, 14.71%
Weight Decreased: 3 people, 4.41%
Thyroid Cancer: 3 people, 4.41%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 3 people, 4.41%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 4.41%
High Blood Pressure: 3 people, 4.41%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 4.41%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 2.94%
Diabetes: 2 people, 2.94%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 1.47%

* Approximation only. Some reports may have incomplete information.

Do you take Ultravist 370 and have Cardiac arrest?

- Check whether Cardiac arrest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultravist 370:

Ultravist 370 (1,334 reports)

Cardiac arrest treatments and more:

Cardiac arrest (101,931 reports)

Browse all side effects of Ultravist 370:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac arrest:

Cardiac arrest (2,236 drugs)

Browse all the conditions that are associated with Cardiac arrest:

Cardiac arrest (2,512 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iopromide (the active ingredients of Ultravist 370) and Ultravist 370 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.